Truncated ErbB2 Expressed in Tumor Cell Nuclei Contributes to Acquired Therapeutic Resistance to ErbB2 Kinase Inhibitors
2011 · Molecular Cancer Therapeutics · 50 citations
https://doi.org/10.1158/1535-7163.mct-10-0991
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.2K
Citations
20
h-index
32
i10-index
Rongrong Zong is an academic researcher from Xiamen University. The author has contributed to research in topics: Ocular Surface and Contact Lens & Corneal Surgery and Treatments & Glaucoma and retinal disorders. The author has an h-index of 20, co-authored 44 publications.
https://doi.org/10.1158/1535-7163.mct-10-0991
https://doi.org/10.1016/j.exer.2011.04.003
https://doi.org/10.1038/srep10630
https://doi.org/10.1186/s12957-023-03142-2
https://doi.org/10.1167/iovs.66.3.2
Click to start Chat